Carlo Aquino (left) and “Shogun” star Takehiro Hira within the official trailer of “Crosspoint.” | Picture: Screengrab from YouTube/CROSSPOINT
Filipino actor Carlo Aquino and Japanese star Takehiro Hira, identified for his function within the award-winning sequence “Shogun,” are set to group up within the upcoming Philippine and Japanese impartial collaboration movie “Crosspoint.”
The official trailer of the action-drama has been launched and it confirmed Manuel (Aquino) and Shigeru (Hira) stumbling upon one another in Japan. The pair got here to an settlement about discovering a needed individual to say the 10-million yen reward to make ends meet.
The one minute and 30 second clip gave a glimpse of Aquino and Hira’s characters’ distressing, action-packed lives.
In an interview with TV Patrol, Aquino shared that it was an “achievement” for him to have labored with the Hollywood actor.
“Ang daming guidelines para sakin, Japan shoot, kasama ko si Takehiro Hira. ‘Yung pagdating niya sa set alam niya na lahat. ‘Yung blocking na lang ‘yung aaralin namin, saka kapag nagre-rehearsal ginagawa niya na kung ano ‘yung gagawin niya sa take,” he mentioned.
Article continues after this commercial
Directed by Donie Ordiales, “Crosspoint” will premiere in Philippine cinemas on Oct. 16 and is slated for a screening in Japan subsequent 12 months. It should additionally function Sarah Jane Abad, Kei Kurosawa, Ian de Leon, Zeppi Borromeo, Dindo Arroyo and Polo Ravales.
In the meantime, Hira was lately nominated for Excellent Supporting Actor in a Drama Sequence for his function as Ishido Kazunari in “Shogun,” which obtained a historic 25 nominations and gained 18 of them on the 2024 Primetime Inventive Arts Emmys.
Then again, Aquino can also be set to seem in one other massive native venture, the Philippine adaptation of Korean drama “It’s Okay To Not Be Okay,” the place he shall be taking part in an grownup who’s a part of the autism spectrum.
Aquino shall be joined by Anne Curtis and Joshua Garcia, amongst others, within the mentioned sequence.
Your subscription couldn’t be saved. Please attempt once more.
Your subscription has been profitable.
